Loading...
Expert
Menu
Mohamed Hegazy MD MRCPI EDIC Clinical research sub-investigator.
Riyadh, Saudi Arabia
Mohamed Hegazy MD MRCPI EDIC
Clinical research sub-investigator.
I specialize in Critical Care Medicine as an assistant consultant in NGHA Riyadh Saudi Arabia.
I graduated from Cairo University with an MBBCH in Medicine and Surgey in 2008.
I started my training and worked as an ICU resident in Cairo in the National Institute of Diabetes and Endocrinology. Then, I joined NGHA as a specialist (staff physician) in 2014 until I was eventually promoted to assistant consultant in 2021.
Meanwhile, I have finished MRCPI membership of the Royal College of Ireland in General Medicine, then European Diploma in Intensive Care Medicine from the European Society of Intensive Care Medicine.
I have been participating in clinical research within our department, namely…
0
Calls |
0
Reviews |
Healthcare
Pharmaceuticals
Medicine
Member since February 2023
Areas of Expertise
-
$3.33/min per minuteNew ArrivalCritical Care MedicineMohamed Hegazy • Riyadh, Saudi ArabiaCreated 2 years ago in OtherMohamed Hegazy MD MRCPI EDIC Clinical research sub-investigator. I specialize in Critical Care Medicine as an assistant consultant in NGHA Riyadh Saudi Arabia. I graduated from Cairo University with an MBBCH in Medicine and Surgey in 2008. I started my training and worked as an ICU resident in Cairo in the National Institute of Diabetes and Endocrinology. Then, I joined NGHA as a specialist (staff physician) in 2014 until I was eventually promoted to assistant consultant in 2021. Meanwhile, I have finished MRCPI membership of the Royal College of Ireland in General Medicine, then European Diploma in Intensive Care Medicine from the European Society of Intensive Care Medicine. I have been participating in clinical research within our department, namely: -Co-author of “Occlusion of the Endotracheal Tube in Ventilated Critically Ill Patients: Risk Factors and Outcomes” manuscript. -Co-author of "Venous thromboembolism in critically ill patients with severe COVID-19: a retrospective study on prevalence, thromboprophylaxis and outcomes in a tertiary-care ICU". -Sub-investigator in REVISE "Re-EValuating the Inhibition of Stress Erosions"multicenter clinical trial. -Sub-investigator in REMAP-CAP multicenter international clinical trial. -Sub-investigator in REPLENISH "Replacing protein via enteral nutrition in a stepwise approach in critically ill patients, a Randomized Controlled Trial" -Sub-investigator in BALANCE "Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness"multicenter clinical trial. -Sub-investigator in The PROMIZING Study "Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation". -Sub-investigator in TAME cardiac arrest: A phase III multicenter randomized trial of targeted therapeutic mild hypercapnia after resuscitated cardiac arrest. -Sub-investigator in PREVENT "Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis" multicenter clinical trial, KAIRMC. -Sub-investigator in PROSPECT "Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial" multicenter clinical trial. -Sub-investigator in SPICE III "Early sedation with dexmedetomidine in ventilated critically ill patients" multicenter clinical trial. -Sub-investigator in Treg Cell clinical trial, KAIMRC.Mohamed Hegazy Riyadh, Saudi ArabiaNew Arrival
Healthcare
Pharmaceuticals
Medicine